🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, double-blind, multi-center, placebo-controlled, parallel-g...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01482403
This is a national, prospective, multicenter, comparative, randomized, sing...
Status
Terminated
Location
CHU d'Amiens
Start Date
2019-07-08
Trial ID
NCT03803722
Treatments Being Tested
The Investigators are researching how to improve the treatment currently av...
Status
Recruiting
Location
Peritoneal Malignancy Institute Basingstoke - Hampshire Hospitals NHS Foundation Trust
Start Date
2024-12-04
Trial ID
NCT06513065
Treatments Being Tested
This is a phase 1 open-label study to evaluate the safety and immunogenicit...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2020-02-13
Trial ID
NCT03956056
Treatments Being Tested
Rationale of study: Separators placement is the primary step in orthodonti...
Status
Unknown
Location
Sadaf Bashir
Start Date
2022-01-10
Trial ID
NCT05777122
Treatments Being Tested
Diffuse large B cell lymphoma is the most common histology of non-Hodgkin's...
Status
Recruiting
Location
CHU Jean Minjoz
Start Date
2021-09-08
Trial ID
NCT04670029
Treatments Being Tested
Across sub-Saharan Africa, school-age children bear an under-appreciated bu...
Status
Unknown
Location
Multiple Locations
Start Date
2024-06-01
Trial ID
NCT06424002
Treatments Being Tested
Dolutegravir (DTG) is an HIV-1 integrase inhibitor approved in the United S...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-07
Trial ID
NCT02185300
Treatments Being Tested
The researchers are doing this study to find out whether PK-targeted fludar...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2025-10-20
Trial ID
NCT07223021
Treatments Being Tested
This study is a prospective, single-center, phase Ib/II clinical trial desi...
Status
Not Yet Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2026-08-01
Trial ID
NCT07687004
Treatments Being Tested